Sept 21 (Reuters) – Dri Healthcare Trust: * DRI HEALTHCARE ANNOUNCES US$316 MILLION PURCHASE OF TAVAPADON ROYALTY * DRI HEALTHCARE TRUST – ENTERS AGREEMENTS TO BUY TAVAPADON ROYALTY RIGHTS FROM BAIN
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Sept 21 (Reuters) - The weight-loss drug market is booming, with biotech firms racing to…
Sept 21 (Reuters) - Payments and banking solutions provider Priority Technology Holdings said on Monday…
Sept 21 (Reuters) - Johnson & Johnson said on Monday its experimental use of Caplyta…
(adds Defence Ministry statement, paragraph 6) ALEPPO, Syria, Sept 21 (Reuters) - A series of…
VIDEO SHOWS: FILE FOOTAGE OF SWITZERLAND MIDFIELDER GRANIT XHAKA SHOWS: VANCOUVER, CANADA (JULY 5, 2026)…
Sept 21 (Reuters) - Celanese Corp: * CELANESE CORP - ANNOUNCES GLOBAL PRICE INCREASES FOR…